Mani A. Vannan, MBBS

Mani Vannan practices at Piedmont Hospital in Atlanta, Georgia.

Mani Vannan's NPI, 1548354806, was assigned on October 3, 2006. Mani Vannan holds Georgia license 068332.

Mani Vannan's primary practice is Piedmont Hospital, at 1968 Peachtree NW Rd, Atlanta, GA 30309 in Fulton County. The practice phone is (404) 605-5000.

Mani Vannan's primary practice is Piedmont Hospital in Atlanta, Georgia. The medical group on file is Piedmont Heart Institute. Dmand AI also links Mani Vannan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mani Vannan practices. Vendor and product names are available with a free account.

Cardiovascular disease is Mani Vannan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Mani Vannan's licenses on file in 2 states: Georgia and Ohio.

CMS data shows 50 Medicare services from Mani Vannan across 2 procedure codes in 2024, for 57 Medicare patients. Medicare paid $4,426 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 57 Medicare patients who saw Mani Vannan in 2024. The largest group is 75 to 84, with 25 patients. 75% of them have heart failure, and 75% have high blood pressure. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mani Vannan's median patient age at 61, with 56% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 68 out of 100 for Mani Vannan for performance year 2024, reported as part of a group.

Dmand AI links 82 papers to Mani Vannan, published from 2011 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Echocardiography, Three-Dimensional, Aortic Valve Stenosis and Echocardiography. Mani Vannan has published most often in Eur Heart J Cardiovasc Imaging. Mani Vannan's most frequent co-authors are Zhen Jason Qian, MD, Pradeep Yadav, MD and Stephen H. Little, MD.

Dmand AI links Mani Vannan to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Mitral Valve Insufficiency and Heart Valve Diseases.

CMS Open Payments shows 796 general payments to Mani Vannan from 20 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 58% of the total. Siemens Medical Solutions USA, Inc. paid the most, $176,580. It also lists 1 research payment totaling $2,296 in 2018.